U.S. Physical Therapy (NYSE:USPH) Reaches New 12-Month Low – Here’s What Happened

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) reached a new 52-week low on Monday . The stock traded as low as $69.99 and last traded at $70.70, with a volume of 2506 shares trading hands. The stock had previously closed at $71.93.

Analyst Ratings Changes

A number of analysts have weighed in on the stock. JMP Securities began coverage on shares of U.S. Physical Therapy in a report on Monday, December 16th. They set an “outperform” rating and a $113.00 target price on the stock. William Blair reiterated a “market perform” rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. Citizens Jmp upgraded U.S. Physical Therapy to a “strong-buy” rating in a research note on Monday, December 16th. Bank of America upgraded U.S. Physical Therapy from a “neutral” rating to a “buy” rating and increased their price target for the stock from $100.00 to $115.00 in a research report on Monday, December 16th. Finally, Barrington Research reduced their price objective on U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating for the company in a research report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $109.00.

U.S. Physical Therapy Trading Down 0.5 %

The firm’s 50-day simple moving average is $83.25 and its 200 day simple moving average is $86.59. The stock has a market cap of $1.09 billion, a P/E ratio of 75.89, a PEG ratio of 3.54 and a beta of 1.51. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). The business had revenue of $180.45 million during the quarter, compared to the consensus estimate of $173.10 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. As a group, equities research analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 14th will be issued a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.52%. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.44. The ex-dividend date of this dividend is Friday, March 14th. U.S. Physical Therapy’s dividend payout ratio (DPR) is 97.83%.

Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the firm’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $82.11, for a total transaction of $142,050.30. Following the transaction, the chief operating officer now owns 7,168 shares of the company’s stock, valued at approximately $588,564.48. This trade represents a 19.44 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 1.70% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in USPH. Intech Investment Management LLC bought a new position in U.S. Physical Therapy during the 3rd quarter valued at $356,000. Quantbot Technologies LP lifted its holdings in shares of U.S. Physical Therapy by 57.6% in the third quarter. Quantbot Technologies LP now owns 10,876 shares of the company’s stock valued at $920,000 after buying an additional 3,973 shares during the period. BNP Paribas Financial Markets boosted its stake in U.S. Physical Therapy by 283.0% during the third quarter. BNP Paribas Financial Markets now owns 16,842 shares of the company’s stock valued at $1,425,000 after buying an additional 12,445 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in U.S. Physical Therapy by 57.1% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,631 shares of the company’s stock worth $223,000 after acquiring an additional 956 shares during the period. Finally, Rockefeller Capital Management L.P. raised its position in U.S. Physical Therapy by 18.8% in the third quarter. Rockefeller Capital Management L.P. now owns 160,441 shares of the company’s stock worth $13,578,000 after acquiring an additional 25,393 shares in the last quarter.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.